Brad Armstrong is a well-versed individual with over 25 years of experience in cross-border transactions. Brad's expertise lies in funding venture companies with disruptive technologies for rapid market entry, and he has worked with some of the leading venture capital funds in Silicon Valley and Asia. He is fluent in Chinese and Japanese, which gives him an edge while working in non-for-profit healthcare for over 30 years, focusing on infectious diseases and public health.

Bradford's organizational affiliations have been diverse and widespread, ranging from being the founder and CEO of Fungal Diagnostics to Senior Advisor's role at Vaultex Exchange. He has also been involved in several notable ventures like NEXT LEVEL DIAGNOSTIC LLC, Sino American Infectious Disease Association, 3VR Video Intelligence Platform, Pivot3, Baryon Capital, Equallogic Storage, and many more.

Bradford Armstrong's academic background is extensive, having studied at various universities worldwide -Columbia University in the City of New York, Hokkaido University, National Taiwan University, Beijing Foreign Studies University among others.

Bradford's global competence and versatile experience make him an expert on cross-border transactions and investments. He is a valuable asset to any organization focusing on venture capital, cross-border investments, public health, and infectious diseases.